Biomarker Discovery and Application in Bladder Cancer: Identification and Detection of Gene Methylation, Tumor Specific Antigenes Markers of BCG Treatment.
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Bladder Cancer
Both
Bladder Cancer
Trial Information
Biomarker Discovery and Application in Bladder Cancer: Identification and Detection of Gene Methylation, Tumor Specific Antigenes Markers of BCG Treatment.
Inclusion Criteria:
- Over 18 years old
Exclusion Criteria:
- No exclusion criteria
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Authority:
Israel: Israeli Health Ministry Pharmaceutical Administration
Study ID:
MDL0806
NCT ID:
NCT00962052
Start Date:
July 2009
Completion Date:
December 2011
Related Keywords:
- Bladder Cancer
- Urinary Bladder Neoplasms
Name | Location |
|---|
